Closing Bell: Nervgen Pharma Corp up on Tuesday (NGEN)

Today in trading, Nervgen Pharma Corp shares opened at $2.82 and closed at $2.89. Intraday prices ranged from $2.77 to $2.92.

Shares advanced 7.43% from the previous day's close of $2.69.

During the day across North America, the TSX Composite closed 0.36% at 21953.80, the S&P 500 closed 0.27% at 5475.09, the Dow Jones Industrial Average closed 0.13% at 39169.52 and the Nasdaq Composite closed 0.83% at 17879.30.

Nervgen Pharma Corp traded under NGEN on the Toronto Venture Exchange (TSX-V).

A total of 45,047 shares was traded during the last trading day, with total trades of 166, with an average volume of 114,423 over 5 days.

Trading across the entire TSX-V saw 2,828 price advancers against 2,436 declines and 102 unchanged.

During the prior 52 weeks, NGEN.VN has traded as high as $3.98 (February 05,2024) and low as $1.58 (December 14,2023). Moreover, the shares have advanced 76.22% in the last 52 weeks, while they have advanced 7.04% this year.

Following today's trading, Nervgen Pharma Corp has a market capitalization of $188.10 million on a float of 69,928 shares outstanding. Its annual EPS is $-0.34.

Nervgen Pharma Corp is a TSX Biotechnology company headquartered in Vancouver, CAN.

Based on 0.00 analysts, Nervgen Pharma Corp gets an average recommendation of "Strong Sell" according to Zacks. From those 0 analysts,.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..